Cargando…
Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro
Histone deacetylases (HDACs) exhibit increased expression in cancer and promote oncogenesis via the acetylation of or interactions with key transcriptional regulators. HDAC inhibitors (HDACis) decrease HDAC activity to selectively inhibit the occurrence and development of tumors. Our study screened...
Autores principales: | Bai, Miao, Cui, Mengqi, Li, Mingyue, Yao, Xinlei, Wu, Yulun, Zheng, Lihua, Sun, Luguo, Song, Qiuhang, Wang, Shuyue, Liu, Lei, Yu, Chunlei, Huang, Yanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416734/ https://www.ncbi.nlm.nih.gov/pubmed/34512161 http://dx.doi.org/10.7150/ijbs.62339 |
Ejemplares similares
-
Tectorigenin targets PKACα to promote GLUT4 expression in skeletal muscle and improve insulin resistance in vitro and in vivo
por: Yao, Xinlei, et al.
Publicado: (2023) -
A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4
por: Song, Qiuhang, et al.
Publicado: (2019) -
Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo
por: Li, Yan, et al.
Publicado: (2017) -
Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
por: Chan, Daniel, et al.
Publicado: (2013) -
FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion
por: Shao, Wenjun, et al.
Publicado: (2023)